Real-World Data from the First US Commercial Users of an Implantable Continuous Glucose Sensor

Abstract Background: The Eversense® Continuous Glucose Monitoring (CGM) System, with the first 90-day implantable sensor, received FDA (Food and Drug Administration) approval in June 2018. No real-...